Medical News

RSS

Endo International’s revenues increase $800 million to 37% in fourth quarter 2014

Endo International plc today reported fourth quarter 2014 revenues of $800 million, an increase of 37 percent compared to fourth quarter 2013 revenues of $585 million, including new product revenue from 2014 strategic M&A transactions.

2 Mar 2015

BioScrip’s total revenue increases $28.2 million to 2.5% in fourth quarter 2014

BioScrip®, Inc. today announced 2014 fourth quarter financial results. Fourth quarter revenue from continuing operations was $253.7 million and the net loss from continuing operations was $61.9 million, or $0.90 per basic and diluted share.

2 Mar 2015

Celimmune licenses anti-IL-15 monoclonal antibody from Amgen

Celimmune LLC, a clinical development-stage immunotherapy company focused on treating and preventing autoimmune diseases, announced today that it has licensed a Phase 2-stage, anti-IL-15 monoclonal antibody (AMG 714) from Amgen.

2 Mar 2015

Researchers use satellite technology to assess quality of water on Earth

An international team of researchers has demonstrated a way to assess the quality of water on Earth from space by using satellite technology that can visualise pollution levels otherwise invisible to the human eye through 'Superhero vision'.

2 Mar 2015

Neurotechnology introduces SentiGaze Software Development Kit

Neurotechnology, a provider of high-precision biometric, robotics and AI technologies, today introduced the SentiGaze Software Development Kit (SDK).

2 Mar 2015

Study shows importance of disclosing physician conflicts of interest in MS ISCTs to potential participants

If you're one of the nearly half a million Americans living with multiple sclerosis (MS) - a slowly disabling disease of the central nervous system - you are likely dependent on disease-modifying drugs to prevent symptoms such as vision problems, balance issues and weakness. Often, these treatments have been developed through pharmaceutical industry-sponsored clinical trials (ISCT) in collaboration with academic or private practice physicians who care for MS patients.

2 Mar 2015

Cancer Care Ontario raises awareness about colorectal cancer

March is Colorectal Cancer Awareness Month and Cancer Care Ontario (CCO) is on a mission to raise awareness about an organ that doesn't get the attention it deserves.

2 Mar 2015

Qualcomm launches Snapdragon Sense ID 3D Fingerprint Technology

Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, is extending its mobile security leadership with the launch of Qualcomm Snapdragon Sense ID 3D Fingerprint Technology, the mobile industry's first 3D fingerprint authentication technology based on ultrasonic technology.

2 Mar 2015

BioMed Realty recaptures valuable properties in Cambridge innovation district

BioMed Realty Trust, Inc. (NYSE: BMR) today announced it has recaptured approximately 313,000 square feet of space in the most dynamic and valuable life science real estate market in the world through the termination of Vertex Pharmaceuticals' leases on three properties in Cambridge, Massachusetts effective February 28, 2015.

2 Mar 2015

Three hospitals jointly accredited as FIFA Medical Centre of Excellence

Three hospitals--Kobe University Hospital, Hyogo Prefectural Rehabilitation Central Hospital, and Meiwa Hospital--were jointly accredited as a Federation Internationale de Football Association Medical Centre of Excellence.

2 Mar 2015

Oncolytics' REOLYSIN granted FDA Orphan Drug Designation for treatment of fallopian tube cancer

Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of cancer of the fallopian tube.

2 Mar 2015

Taiho announces submission of TAS-102 MAA to EMA for treatment of mCRC

Taiho Pharma Europe Ltd., a subsidiary of Japan based Taiho Pharmaceutical Co., Ltd., announced that it has submitted a Marketing Authorisation Application to the European Medicines Agency for TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), an oral combination anticancer drug intended for use in the treatment of refractory metastatic colorectal cancer (mCRC).

2 Mar 2015

Transition completes enrolment of patients in ELND005 Phase 2 study for treatment of AD patients

Transition Therapeutics Inc. announced that its wholly owned subsidiary, Transition Therapeutics Ireland Limited completed enrolment of the Phase 2 clinical study evaluating neuropsychiatric drug candidate ELND005 as a treatment for agitation and aggression in patients with mild, moderate and severe Alzheimer's disease ("AD").

2 Mar 2015

Bielefeld University chemists develop copper molecule that could help prevent spread of cancer

Chemists at Bielefeld University have developed a molecule containing copper that binds specifically with DNA and prevents the spread of cancer. First results show that it kills the cancer cells more quickly than cisplatin - a widely used anti-cancer drug that is frequently administered in chemotherapy.

2 Mar 2015

Modified measles vaccine effective against Chikungunya virus, study finds

A modified, conventional measles vaccine has the potential to act against the Chikungunya virus. This is the result of a study at the University Clinic for Clinical Pharmacology of the MedUni Wien (Medical University of Vienna), which has now been published in the top journal "The Lancet Infectious Diseases".

2 Mar 2015

U-M researchers reveal key role of two enzymes that help the body to remove cholesterol, other lipids

With the aid of X-ray crystallography, researchers at the University of Michigan have revealed the structures of two closely related enzymes that play essential roles in the body's ability to metabolize excess lipids, including cholesterol.

2 Mar 2015

Study explores use of antipsychotic medications among pediatric patients

More kids nationwide are taking medications designed to treat such mental illnesses as schizophrenia and bipolar disorder, and pediatricians and psychiatrists at the University of Vermont want to know why.

2 Mar 2015

PTI Launches Game-based Learning for the Pharma, Biotech and Medical Device Industries

Pharmaceutical Training International (PTI), the leading supplier of online and public, event-based training courses for the pharma, biotech and medical device sectors, has launched a range of game-based e-learning courses.

From Pharmaceutical Training International 2 Mar 2015

Minihepcidin reverses iron overload of hemochromatosis, stops susceptibility to infections

Hemochromatosis (HH) is the most common genetic disorder in the western world, and yet is barely known. Only in the US 1 in 9 people carry the mutation (although not necessarily the disease).

2 Mar 2015

Study shows heart valve repair can benefit patients with mitral regurgitation

Patients with severe mitral regurgitation (MR) often suffer from psycho-emotional symptoms, such as depression and anxiety, but after undergoing mitral valve repair surgery patients experience a marked improvement in emotional and physical wellbeing, according to an article in the March 2015 issue of The Annals of Thoracic Surgery.

2 Mar 2015

Medical News

Endo International’s revenues increase $800 million to 37% in fourth quarter 2014

BioScrip’s total revenue increases $28.2 million to 2.5% in fourth quarter 2014

Celimmune licenses anti-IL-15 monoclonal antibody from Amgen

Researchers use satellite technology to assess quality of water on Earth

Neurotechnology introduces SentiGaze Software Development Kit

Study shows importance of disclosing physician conflicts of interest in MS ISCTs to potential participants

Cancer Care Ontario raises awareness about colorectal cancer

Qualcomm launches Snapdragon Sense ID 3D Fingerprint Technology

BioMed Realty recaptures valuable properties in Cambridge innovation district

Three hospitals jointly accredited as FIFA Medical Centre of Excellence

Oncolytics' REOLYSIN granted FDA Orphan Drug Designation for treatment of fallopian tube cancer

Taiho announces submission of TAS-102 MAA to EMA for treatment of mCRC

Transition completes enrolment of patients in ELND005 Phase 2 study for treatment of AD patients

Bielefeld University chemists develop copper molecule that could help prevent spread of cancer

Modified measles vaccine effective against Chikungunya virus, study finds

U-M researchers reveal key role of two enzymes that help the body to remove cholesterol, other lipids

Study explores use of antipsychotic medications among pediatric patients

PTI Launches Game-based Learning for the Pharma, Biotech and Medical Device Industries

Minihepcidin reverses iron overload of hemochromatosis, stops susceptibility to infections

Study shows heart valve repair can benefit patients with mitral regurgitation

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News